USP Drug Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Analgesics
 
 Anesthetics
 
 Anti-Addiction/Substance Abuse Treatment Agents
 
 Antibacterials
 
 Anticonvulsants
 
 Antidementia Agents
 
 Antidepressants
 
 Antiemetics
 
 Antifungals
 
 Antigout Agents
 
 Anti-inflammatory Agents
 
 Antimigraine Agents
 
 Antimyasthenic Agents
 
 Antimycobacterials
 
 Antineoplastics
 
 Antiparasitics
 
 Antiparkinson Agents
 
 Antipsychotics
 
 Antispasticity Agents
 
 Antivirals
 
 Anxiolytics
 
 Bipolar Agents
 
 Blood Glucose Regulators
   Antidiabetic Agents
     Acarbose
     Miglitol
       D00625  Miglitol (JP17/USAN/INN)
     Pramlintide [DG:DG00120]
     Metformin [DG:DG00113]
     Colesevelam [DG:DG00361]
     Alogliptin
     Linagliptin
     Saxagliptin [DG:DG00119]
     Sitagliptin [DG:DG00118]
     Bromocriptine [DG:DG00452]
     Albiglutide
     Dulaglutide
     Exenatide
     Liraglutide
     Lixisenatide
     Nateglinide
     Repaglinide
     Canagliflozin
     Dapagliflozin [DG:DG00122]
     Empagliflozin
     Chlorpropamide
     Glimepiride
     Glipizide
     Glyburide
     Tolazamide
     Tolbutamide [DG:DG00115]
     Pioglitazone [DG:DG00117]
     Rosiglitazone [DG:DG00116]
   Glycemic Agents
   Insulins
 
 Blood Products/Modifiers/Volume Expanders
 
 Cardiovascular Agents
 
 Central Nervous System Agents
 
 Dental and Oral Agents
 
 Dermatological Agents
 
 Electrolytes/Minerals/Metals/Vitamins
 
 Gastrointestinal Agents
 
 Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
 
 Genitourinary Agents
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 
 Hormonal Agents, Suppressant (Adrenal)
 
 Hormonal Agents, Suppressant (Pituitary)
 
 Hormonal Agents, Suppressant (Thyroid)
 
 Immunological Agents
 
 Inflammatory Bowel Disease Agents
 
 Metabolic Bone Disease Agents
 
 Ophthalmic Agents
 
 Otic Agents
 
 Respiratory Tract/Pulmonary Agents
 
 Skeletal Muscle Relaxants
 
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 12, 2017
According to the USP Medicare Model Guidelines v7.0

» Japanese version